Samsung Biologics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

삼성바이오로직스KRX:207940 · KOSPI · Healthcare

₩1,359,000-4.16%

2026-10-02 close

Samsung Biologics's published financial data is dated 2026-10-04. 2024 revenue was KRW 4.55T. 2024 operating profit was KRW 1.26T.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy